Gopa Iyer

2011–2025 年に発表

115
論文数
23,864
被引用数
55
h 指数
103
i10 指数

被引用数

Gopa Iyer の年別被引用数1952 年: 被引用 1 件1976 年: 被引用 2 件1977 年: 被引用 1 件1992 年: 被引用 2 件1998 年: 被引用 1 件1999 年: 被引用 1 件2004 年: 被引用 2 件2007 年: 被引用 1 件2009 年: 被引用 5 件2010 年: 被引用 3 件2012 年: 被引用 4 件2013 年: 被引用 24 件2014 年: 被引用 79 件2015 年: 被引用 73 件2016 年: 被引用 103 件2017 年: 被引用 165 件2018 年: 被引用 319 件2019 年: 被引用 1,009 件2020 年: 被引用 1,494 件2021 年: 被引用 1,472 件2022 年: 被引用 1,230 件2023 年: 被引用 986 件2024 年: 被引用 1,622 件2025 年: 被引用 836 件2026 年: 被引用 32 件1953〜1975 年は被引用が無いため表示していません1978〜1991 年は被引用が無いため表示していません1993〜1997 年は被引用が無いため表示していません2000〜2003 年は被引用が無いため表示していません2005〜2006 年は被引用が無いため表示していません2008 年は被引用が無いため表示していません2011 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,894 件、この内訳の 28.3%中国: 引用元論文 1,764 件、この内訳の 12.8%イギリス: 引用元論文 813 件、この内訳の 5.9%イタリア: 引用元論文 698 件、この内訳の 5.1%ドイツ: 引用元論文 689 件、この内訳の 5%フランス: 引用元論文 536 件、この内訳の 3.9%カナダ: 引用元論文 487 件、この内訳の 3.5%スペイン: 引用元論文 487 件、この内訳の 3.5%日本: 引用元論文 455 件、この内訳の 3.3%オランダ: 引用元論文 393 件、この内訳の 2.8%スイス: 引用元論文 326 件、この内訳の 2.4%オーストラリア: 引用元論文 317 件、この内訳の 2.3%
0%28.3%その他 21.2%

分野

  • Medicine62.2%
  • Biochemistry, Genetics and Molecular Biology32.3%
  • Immunology and Microbiology2.8%
  • Computer Science1.3%
  • Engineering0.3%
  • Neuroscience0.2%
  • その他0.9%

トピック

  • Cancer Genomics and Diagnostics8.7%
  • Cancer Immunotherapy and Biomarkers8.1%
  • Bladder and Urothelial Cancer Treatments4.6%
  • Lung Cancer Treatments and Mutations3.8%
  • Ferroptosis and cancer prognosis3.1%
  • Urinary and Genital Oncology Studies2.4%
  • その他69.3%

共著者

全論文

検索で開く
  1. Tumor mutational load predicts survival after immunotherapy across multiple cancer types

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philip H. Gutin, Cameron Brennan, Viviane Tabar, Ingo K. Mellinghoff, Lisa M. DeAngelis, Charlotte E. Ariyan, Nancy Y. Lee, William D. Tap, Mrinal M. Gounder, Sandra P. D’Angelo, Leonard B. Saltz, Zsofia K. Stadler, Howard I. Scher, José Baselga, Pedram Razavi, Christopher A. Klebanoff, Rona Yaeger, Neil H. Segal, Geoffrey Y. Ku, Ronald P. DeMatteo, Marc Ladanyi, Naiyer A. Rizvi, Michael F. Berger, Nadeem Riaz, David B. Solit, Timothy A. Chan, Luc G.T. Morris - Nature Genetics 2019 被引用: 4,358

  2. OncoKB: A Precision Oncology Knowledge Base

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Antonio Omuro, Michael A. Postow, Dana E. Rathkopf, Alexander N. Shoushtari, Neerav Shukla, Martin H. Voss, Ederlinda Paraiso, Ahmet Zehir, Michael F. Berger, Barry S. Taylor, Leonard B. Saltz, Gregory J. Riely, Marc Ladanyi, David M. Hyman, José Baselga, Paul Sabbatini, David B. Solit, Nikolaus Schultz - JCO Precision Oncology 2017 被引用: 2,698

  3. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Laetitia Borsu, Justyna Sadowska, Jacklyn Casanova, Ruben Bacares, Iwona Kiecka, Anna Razumova, Julie B Son, Lisa Stewart, Tessara Baldi, Kerry Mullaney, Hikmat Al‐Ahmadie, Efsevia Vakiani, Adam Abeshouse, Alexander Penson, Philip Jonsson, Niedzica Camacho, Matthew T. Chang, Helen Won, Benjamin Groß, Ritika Kundra, Zachary Heins, Hsiao‐Wei Chen, Sarah Phillips, Hongxin Zhang, Jiaojiao Wang, Angelica Ochoa, Jonathan Wills, Michael Eubank, Stacy B. Thomas, Stuart M. Gardos, Dalicia N. Reales, Jesse Galle, Robert Durany, Roy Cambria, Wassim Abida, Andrea Cercek, Darren R. Feldman, Mrinal M. Gounder, A. Ari Hakimi, James J. Harding, Gopa Iyer, Yelena Y. Janjigian, Emmet Jordan, Ciara M. Kelly, Maeve A. Lowery, Luc G.T. Morris, Antonio Omuro, Nitya Raj, Pedram Razavi, Alexander N. Shoushtari, Neerav Shukla, Tara E. Soumerai, Anna M. Varghese, Rona Yaeger, Jonathan Coleman, Bernard H. Bochner, Gregory J. Riely, Leonard B. Saltz, Howard I. Scher, Paul Sabbatini, Mark E. Robson, David S. Klimstra, Barry S. Taylor, José Baselga, Nikolaus Schultz, David M. Hyman, Maria E. Arcila, David B. Solit, Marc Ladanyi, Michael F. Berger - Nature Medicine 2017 被引用: 3,517

  4. Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2024 被引用: 914

  5. Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yelena Y. Janjigian, Michael J. Morris, Robert J. Motzer, Eileen M. O’Reilly, Michael A. Postow, Nitya Raj, Gregory J. Riely, Mark E. Robson, Jonathan E. Rosenberg, Anton Safonov, Alexander N. Shoushtari, William D. Tap, Min Yuen Teo, Anna M. Varghese, Martin H. Voss, Rona Yaeger, Marjorie G. Zauderer, Nadeem R. Abu‐Rustum, Julio García‐Aguilar, Bernard H. Bochner, A. Ari Hakimi, William R. Jarnagin, David R. Jones, Daniela Molena, Luc G.T. Morris, Eric Rios‐Doria, Paul Russo, Samuel Singer, Vivian E. Strong, Debyani Chakravarty, Lora H. Ellenson, Anuradha Gopalan, Jorge S. Reis‐Filho, Britta Weigelt, Marc Ladanyi, Mithat Gönen, Sohrab P. Shah, Joan Massagué, Jianjiong Gao, Ahmet Zehir, Michael F. Berger, David B. Solit, Samuel F. Bakhoum, Francisco Sánchez-Vega, Nikolaus Schultz - Cell 2022 被引用: 663

  6. Genome doubling shapes the evolution and prognosis of advanced cancers

    著者: , , , , , , , , , , , , , , , , , , , - Nature Genetics 2018 被引用: 692

  7. HER kinase inhibition in patients with HER2- and HER3-mutant cancers

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alexander Drilon, James J. Harding, Gopa Iyer, Barry S. Taylor, Michael F. Berger, Richard E. Cutler, Feng Xu, Anna Butturini, Lisa D. Eli, Grace Mann, Cynthia Farrell, Alshad S. Lalani, Richard Bryce, Carlos L. Arteaga, Funda Meric‐Bernstam, José Baselga, David B. Solit - Nature 2018 被引用: 788

  8. Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alison Y. Zhang, Hans Prenen, Jean‐Charles Goeminne, Jean‐Pascal Machiels, Sylvie Rottey, Marcelo Corassa, Graziela Zibetti Dal Molin, Katsuki Arima Tiscoski, Denis L. Jardim, Milena Perez Mak, Wei Fu, Herui Yao, Jing Huang, Haiping Jiang, Jing Huang, Baoshi Chen, Dong Yan, Yu Yang, Yohann Loriot, Christophe Le Tourneau, Nicolas Penel, Sébastien Salas, Jean‐Yves Blay, Pierre-Emmanuel Brachet, Xavier Durando, Sheik Emambux, Alain Ravaud, Gunnar Folprecht, Dirk Arnold, Martin Schüler, Marit Ahrens, Alexander Golf, Georg Martin Haag, Florian Lordick, Alexander Desuki, Marina Elena Cazzaniga, Fortunato Ciardiello, Michèle Milella, Takafumi Koyama, Yoshiki Hirooka, Wataru Okamoto, Kenjiro Aogi, Yasutoshi Kuboki, Jung-Yun Lee, Sung‐Bae Kim, Myung‐Ju Ahn, Jong Hee Chang, Yongman Kim, Do‐Hyun Nam, Jaesung Park, Iwona Ługowska, Luis Paz‐Ares, Víctor Moreno, Andrés Cervantes, Mariona Calvo, Alejandro Falcón, Antonio González, Josep Tabernero, A. Martinez Bueno, Javier García-Corbacho, Federico Longo, Chia‐Jui Yen, Jen‐Shi Chen, Ming‐Feng Hou, Yee Chao, Kun‐Ming Rau, Tai‐Jan Chiu, Yin‐Hsun Feng, Chih‐Hung Hsu, Wen‐Tsung Huang ほか 33 名 - The Lancet Oncology 2023 被引用: 200

  9. LBA6 EV-302/KEYNOTE-A39: Open-label, randomized phase III study of enfortumab vedotin in combination with pembrolizumab (EV+P) vs chemotherapy (Chemo) in previously untreated locally advanced metastatic urothelial carcinoma (la/mUC)

    著者: , , , , , , , , , , , , , , , , , , - Annals of Oncology 2023 被引用: 135

  10. Convergent loss of PTEN leads to clinical resistance to a PI(3)Kα inhibitor

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2014 被引用: 590

  11. Somatic ERCC2 Mutations Correlate with Cisplatin Sensitivity in Muscle-Invasive Urothelial Carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stacey Gabriel, Alan D. D’Andrea, Levi A. Garraway, Jonathan E. Rosenberg - Cancer Discovery 2014 被引用: 624

  12. Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2018 被引用: 552

  13. Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael J. Morris, Robert J. Motzer, Eileen M. O’Reilly, Michael A. Postow, Nitya Raj, Gregory J. Riely, Mark E. Robson, Jonathan E. Rosenberg, Anton Safonov, Alexander N. Shoushtari, William D. Tap, Min Yuen Teo, Anna M. Varghese, Martin H. Voss, Rona Yaeger, Marjorie G. Zauderer, Nadeem R. Abu‐Rustum, Julio García‐Aguilar, Bernard H. Bochner, A. Ari Hakimi, William R. Jarnagin, David R. Jones, Daniela Molena, Luc G.T. Morris, Eric Rios‐Doria, Paul Russo, Samuel Singer, Vivian E. Strong, Debyani Chakravarty, Lora H. Ellenson, Anuradha Gopalan, Jorge S. Reis‐Filho, Britta Weigelt, Marc Ladanyi, Mithat Gönen, Sohrab P. Shah, Joan Massagué, Jianjiong Gao, Ahmet Zehir, Michael F. Berger, David B. Solit, Samuel F. Bakhoum, Francisco Sánchez-Vega, Nikolaus Schultz - 2021 被引用: 69

  14. OncoTree: A Cancer Classification System for Precision Oncology

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sarah P. Suehnholz, Moriah H. Nissan, Gopa Iyer, Rajmohan Murali, Nancy Bouvier, Robert A. Soslow, David M. Hyman, Anas Younes, Andrew M. Intlekofer, James J. Harding, Richard D. Carvajal, Paul Sabbatini, Ghassan K. Abou‐Alfa, Luc G.T. Morris, Yelena Y. Janjigian, Meighan M. Gallagher, Tara A. Soumerai, Ingo K. Mellinghoff, A. Ari Hakimi, Matthew G. Fury, Jason T. Huse, Aditya Bagrodia, Meera Hameed, Stacy B. Thomas, Stuart M. Gardos, Ethan Cerami, Tali Mazor, Priti Kumari, Pichai Raman, Priyanka Shivdasani, Suzanne P. MacFarland, Scott Newman, Angela J. Waanders, Jianjiong Gao, David B. Solit, Nikolaus Schultz - JCO Clinical Cancer Informatics 2021 被引用: 150

  15. Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alan Li, Emily S. Lebow, Anita S. Bowman, Donna C. Ferguson, Ying Liu, Douglas A. Mata, Rohit Sharma, Soo‐Ryum Yang, Tejus Bale, Jamal Benhamida, Jason C. Chang, Snjezana Doğan, Meera Hameed, Jaclyn F. Hechtman, Christine Moung, Dara S. Ross, Efsevia Vakiani, Chad Vanderbilt, JinJuan Yao, Pedram Razavi, Lillian M. Smyth, Sarat Chandarlapaty, Gopa Iyer, Wassim Abida, James J. Harding, Benjamin A. Krantz, Eileen M. O’Reilly, Helena A. Yu, Bob T. Li, Charles M. Rudin, Luis A. Díaz, David B. Solit, Maria E. Arcila, Marc Ladanyi, Brian Houck‐Loomis, Dana W.Y. Tsui, Michael F. Berger, Ahmet Zehir, Ryma Benayed - Nature Communications 2021 被引用: 183

  16. LAG-3 expression on peripheral blood cells identifies patients with poorer outcomes after immune checkpoint blockade

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2021 被引用: 98

  17. Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets

    著者: , , , , , , , , , , , , , , , , , - European Urology 2017 被引用: 372

  18. Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1 blockade might predict therapy outcome in metastatic urothelial carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2022 被引用: 82

  19. Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysis

    著者: , , , , , , , , , , , , , , , , , , , , - PLoS Medicine 2017 被引用: 367

  20. Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jonathan E. Rosenberg, Min Yuen Teo, Dean F. Bajorin - Journal of Clinical Oncology 2023 被引用: 105

  21. ERCC2 Helicase Domain Mutations Confer Nucleotide Excision Repair Deficiency and Drive Cisplatin Sensitivity in Muscle-Invasive Bladder Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2018 被引用: 162

  22. Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Timothy F. Donahue, Alvin C. Goh, William C. Huang, Dean F. Bajorin, Gopa Iyer, Bernard H. Bochner, Arjun Vasant Balar, Amir Mortazavi, Jonathan E. Rosenberg - Journal of Clinical Oncology 2022 被引用: 99

  23. Genomic heterogeneity as a barrier to precision oncology in urothelial cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Cell Reports 2022 被引用: 70

  24. Clonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial Carcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2018 被引用: 283